Page last updated: 2024-10-20

pyridoxamine and Acute Kidney Injury

pyridoxamine has been researched along with Acute Kidney Injury in 1 studies

Acute Kidney Injury: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.

Research Excerpts

ExcerptRelevanceReference
"Pyridoxamine (PM) is a structural analog of vitamin B6 that interferes with oxidative macromolecular damage via a number of different mechanisms and is in a phase 3 clinical efficacy trial to delay CKD progression in patients with diabetic kidney disease."5.43Pyridoxamine reduces postinjury fibrosis and improves functional recovery after acute kidney injury. ( de Caestecker, CR; de Caestecker, MP; Drouin, M; Harris, RC; Hudson, B; Skrypnyk, NI; Theberge, MC; Voziyan, P; Yang, H, 2016)
"Pyridoxamine (PM) is a structural analog of vitamin B6 that interferes with oxidative macromolecular damage via a number of different mechanisms and is in a phase 3 clinical efficacy trial to delay CKD progression in patients with diabetic kidney disease."1.43Pyridoxamine reduces postinjury fibrosis and improves functional recovery after acute kidney injury. ( de Caestecker, CR; de Caestecker, MP; Drouin, M; Harris, RC; Hudson, B; Skrypnyk, NI; Theberge, MC; Voziyan, P; Yang, H, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Skrypnyk, NI1
Voziyan, P1
Yang, H1
de Caestecker, CR1
Theberge, MC1
Drouin, M1
Hudson, B1
Harris, RC1
de Caestecker, MP1

Other Studies

1 other study available for pyridoxamine and Acute Kidney Injury

ArticleYear
Pyridoxamine reduces postinjury fibrosis and improves functional recovery after acute kidney injury.
    American journal of physiology. Renal physiology, 2016, 08-01, Volume: 311, Issue:2

    Topics: Acute Kidney Injury; Animals; Dose-Response Relationship, Drug; Fibrosis; Isoprostanes; Kidney Tubul

2016